Full-Time

Manager – Pharmacometrician

Posted on 11/20/2024

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$99.9k - $166.5kAnnually

+ Bonus

Junior, Mid

No H1B Sponsorship

Bothell, WA, USA + 2 more

More locations: La Jolla, San Diego, CA, USA | New York, NY, USA

Relocation support available.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Qualifications include PhD, PharmD, or equivalent, including expertise in one or more areas (e.g., pharmacometrics, clinical pharmacology, pharmacokinetics, pharmaceutical sciences, biostatistics, applied mathematics, or related discipline).
  • Up to 4 years of experience in the relevant quantitative field.
  • Strong scientific and quantitative analysis with good working knowledge of pharmacokinetics, pharmacology, pharmaceutics, and/or statistics. Experience in population PK, PK/PD, mechanistic/systems pharmacology or exposure-response modeling and simulation is particularly relevant.
  • Basic understanding/knowledge of pharmacology, biology, physiology/pathophysiology (particularly in oncology), and drug research & development process.
  • Strong communication skills including written, verbal and presentation.
  • Candidates from alternative backgrounds (e.g., mathematics, engineering, system biology, medicine) will be considered if they can demonstrate relevant experience and expertise.
Responsibilities
  • With guidance, provide MIDD expertise on multidisciplinary development teams, working closely with clinical pharmacologists, clinicians, and statisticians, and other scientists to create MIDD plans that include assessments of a drug’s efficacy, safety, and commercial viability.
  • Responsible for the execution of relevant quantitative analyses which may include population pharmacokinetics, pharmacokinetics/pharmacodynamics, exposure response, disease progression modeling, model-based meta-analysis, quantitative knowledge management, and decision analysis for multiple analyses supporting a program.
  • Clearly communicate modeling and simulation results to technical and non-technical audiences internally and externally.
  • Prepare formal presentations and written reports to Pfizer standards.
  • Author, contribute, and perform technical quality control checks for regulatory documents (modeling reports, summary documents, briefing books, regulatory responses).
  • Stay abreast of literature, regulatory guidelines, and internal guidance as relates to pharmacometrics and MIDD, including internal SOPs and regulations in order to be a team resource of pharmacometric knowledge and applications.
  • Contribute to the development or improvement of our tools, processes and methodology, including involvement in internal cross-functional workgroups or initiatives, external alliances or committees, consortia and academic relationships.
  • May train, develop, and mentor less experienced pharmacometricians or other colleagues in systems pharmacology, clinical pharmacology or translational clinical sciences.
  • Contribute to pharmacometrics’ ability to act as a conduit for cross learnings within/across the clinical development organizations. Promote, educate, and mentor others in application of quantitative techniques, best practices, MIDD, and share experiences through appropriate local and global discussions.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?